Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab) Usha Sharma Jun 22, 2015 Ranibizumab is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD), a common degenerative…
